mefloquine has been researched along with Parasitemia in 89 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (24.72) | 18.2507 |
| 2000's | 35 (39.33) | 29.6817 |
| 2010's | 31 (34.83) | 24.3611 |
| 2020's | 1 (1.12) | 2.80 |
| Authors | Studies |
|---|---|
| Girdwood, SC; Mott, BT; Nenortas, E; Posner, GH; Shapiro, TA; Slack, RD; Sullivan, D; Tripathi, A; Triphati, A; Woodard, LE | 1 |
| Avery, VM; Barth, S; Duffy, S; Frank, W; Geffken, D; Held, J; Kamber, J; Kuna, K; Kurz, T; Leven, M; Mordmüller, B; Sax, S; Siethoff, C; Tschan, S; Wittlin, S | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
| Akter, J; Aogo, RA; Best, SE; Cromer, D; Davenport, MP; Elliott, T; Engel, JA; Gartlan, KH; Haque, A; James, KR; Khoury, DS; Sebina, I; Soon, MSF; Thomas, BS | 1 |
| Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO | 2 |
| Abdus-Salam, R; Akinyotu, O; Arowojolu, A; Bello, F | 1 |
| Akter, J; Aogo, RA; Cromer, D; Davenport, MP; Elliott, T; Fogg, LG; Haque, A; Khoury, DS; Laohamonthonkul, P; Liligeto, UN; Nair, AS; Pernold, CPS; Romanczuk, AS; Soon, MSF; Thomas, BS | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Afangnihoun, A; Atadokpede, F; Cot, M; Denoeud-Ndam, L; Dossou-Gbete, L; Fourcade, C; Girard, PM; Komongui, DG; Ndam, NT; Porcher, R; Taron-Brocard, C; Zannou, DM | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Anvikar, AR; Dash, AP; Dubhashi, NG; Ghosh, SK; Jullien, V; Kiechel, JR; Kumar, A; Rao, BH; Sharma, B; Singh, JP; Srivastava, B; Taylor, WR; Valecha, N | 1 |
| Albrecht, L; Angerami, RN; Castiñeiras, CM; Costa, FT; Dos-Santos, JC; Garcia, MT; Lacerda, MV; Levy, CE; Lopes, SC; Moretti, ML | 1 |
| Chandra, R; Dieng, Y; Djimdé, AA; Dunne, MW; Kain, KC; Mugyenyi, P; Mulenga, M; Oduro, AR; Ogutu, B; Robbins, J; Sagara, I; Sarkar, S; Sie, A; Tiono, AB; Wasunna, M | 1 |
| Baker, M; Marquart, L; McCarthy, JS; O'Rourke, P | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA | 1 |
| Bastos, MS; de Melo, GN; de Souza-Lima, Rde C; Ferreira, MU; Ladeia-Andrade, S; Luz, Fd; Rodrigues, PT; Salla, LC | 1 |
| Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
| Agomo, PU; Aina, OO; Ezeiru, VI; Meremikwu, MM; Odey, FA; Oguche, S; Omalu, IJ; Watila, IM | 1 |
| Chaparro Sánchez, MJ; Curiel Balsera, E; Mora Ordóñez, J | 1 |
| Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
| Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
| Bacon, DJ; Durand, S; Ganguly, B; Green, M; Gutman, J; Quezada, WM; Rojas, OV; Ruebush, TK; Slutsker, L; Utz, GC | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Alvarez, LG; Blair, S; Ríos, A; Sanín, F; Tobón, A; Vásquez, AM | 1 |
| Banmairuroi, V; Bualombai, P; Congpuong, K; Na-Bangchang, K | 1 |
| Duangdee, C; Krudsood, S; Looareesuwan, S; Pothipak, N; Tangpukdee, N; Warrell, DA; Wilairatana, P | 1 |
| Alvarez, G; Blair, S; Piñeros, JG; Ríos, A; Tobón, A | 1 |
| Carter, R; Cheesman, S; Culleton, RL; Inoue, M; Reece, SE | 1 |
| Carvalho, LJ; Clemmer, L; Frangos, JA; Martins, YC; Zanini, GM | 1 |
| Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
| Na-Bangchang, K; Ruengweerayut, R; Wernsdorfer, WH | 1 |
| Pandey, SK; Rizvi, A; Tripathi, R | 1 |
| Bentura-Marciano, A; Chan, WC; Clark, J; Golenser, J; Guiguemde, AW; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Wong, HN | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Hatabu, T; Kano, S; Kobayashi, J; Li, C; Mannoor, MK; Phompida, S; Sato, Y; Toma, H; Vanisaveth, V; Watanabe, H | 1 |
| Alker, AP; MacArthur, JR; Meshnick, SR; Satimai, W; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Ariey, F; Duchemin, JB; Harisoa, JL; Mauclere, P; Pietra, V; Rabarijaona, LP; Raharimalala, LA; Rakotomanana, F; Ranaivo, L; Randrianarivelojosia, M; Robert, V | 1 |
| Betschart, B; Jelinek, T; Löscher, T; Nothdurft, HD; Sonnenburg, FV; Wichmann, O | 1 |
| Diarra, A; Konate, A; Moran, AC; Newman, RD; Parise, ME; Sawadogo, R; Sirima, SB; Yameogo, M | 1 |
| Hoelscher, M; Löscher, T | 1 |
| Cabezas, C; Calampa, C; Falconí, E; Huilca, M; Marquiño, W; Naupay, R; Ruebush, TK | 1 |
| Chaikachonpatd, S; Chanthapakajee, K; Chindarat, S; Kaewkaukul, N; Lim, K; Silpasakorn, S; Suputtamongkol, Y; Thamlikitkul, V | 1 |
| Ayomi, E; Baird, JK; Bangs, MJ; Barcus, MJ; Basri, H; Elyazar, IR; Fryauff, DJ; Marwoto, H; Richie, TL | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Avila, JC; Marquiño, W; Mollinedo, R; Ruebush, TK; Villaroel, R; Zegarra, J | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Bégué, JP; Bonnet-Delpon, D; Grellepois, F; Grellier, P | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI | 1 |
| Redig, P; Sagesse, M; Saggese, M; Tavernier, P; Van Wettere, A | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Bhattacharjee, AK; Cabezas, M; Caridha, D; Dow, GS; Gerena, L; Gettayacamin, M; Heady, TN; Lanteri, CA; Obaldia, N; Roncal, N; Shearer, T; Smith, KS; Smith, PL; Tungtaeng, A; Wolf, L; Yourick, D | 1 |
| Aydin, K; Ergüven, S; Ozkaya, G; Unal, S; Yildirim, T | 1 |
| Andrade, AA; Boechat, N; de Freitas, IO; de Pilla Varotti, F; de Souza, MV; Krettli, AU; Vasconcelos, TR | 1 |
| Baird, JK; Binka, F; Fryauff, DJ; Hoffman, SL; Koram, KA; Nkrumah, F; Owusu-Agyei, S; Utz, G | 1 |
| Ahmad, R; Srivastava, AK | 1 |
| Burgner, D; Cherian, S | 1 |
| Barnwell, JW; Bounngaseng, A; Collins, WE; Galland, GG; Grady, KK; Hall, P; Huber, C; Nace, D; Ruebush, TK; Sullivan, JJ; Sullivan, JS; Williams, A; Williams, T | 1 |
| Gozalo, AS; Hall, BT; Lucas, CM; Magill, AJ; Qin, J | 1 |
| Ashley, EA; Lwin, KM; McGready, R; Nosten, F; Proux, S; Silamut, K | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Raimond, SD; White, NJ | 1 |
| do Rosario, VE; Fonseca, L; Seixas, E; Vigario, AM | 1 |
| Del Nero, L; Lamizana, L; Nebié, I; Pietra, V | 1 |
| Basco, LK; Le Bras, J; Makler, MM; Marquet, F | 1 |
| Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
| Breman, JG; Heymann, DL; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Breman, JG; Heymann, DL; Khoromana, CO; Roberts, JM; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Breman, JG; Heymann, DL; Khoromana, CO; Slutsker, L; Steketee, RW; Wirima, JJ | 1 |
| Agbo, M; Emembolu, JO; Lege-Oguntoye, L; Okeyeh, JN | 1 |
| Ilesanmi, AO; Oduola, AM; Salako, LA; Sowunmi, A | 1 |
| Bouquety, JC; Carme, B; Gay, F; Hayette-Gorremans, MP; Ndounga, M | 1 |
| Fleck, SL; Peters, W; Robinson, BL | 1 |
| Chiwakata, CB; Dietrich, M; Egbring, R; Gaus, W; Hassemer, M; Hemmer, CJ; Hogel, J; Hort, G; Kern, P; Nawroth, PP; Seitz, R | 1 |
| Lege-Oguntoye, L; Ogunrinde, GO; Okoyeh, JN; Ugbode, RO | 1 |
| Attanath, P; Brewer, TG; Chanthavanich, P; Chongsuphajaisiddhi, T; Heppner, DG; Mookmanee, D; Phanuaksook, P; Poonpanich, Y; Prarinyanupharb, V; Sabchareon, A; Teja-Isavadharm, P | 1 |
| Boutes, S; Karbwang, J; Na-Bangchang, K; Riengchainam, S; Tan-ariya, P; Ubalee, R | 1 |
| Chongsuphajaisiddhi, T; Looareesuwan, S; Viriyavejakul, P; Wilairatana, P | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; Simpson, JA; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| Hills, F; Krudsood, S; Looareesuwan, S; Porter, RS; Sjostrom, L; Warrell, DA; Wilairatana, P | 1 |
| Collins, WE; Galland, GG; Kaslow, DC; Lal, AA; Morris, CL; Saekhou, AM; Sullivan, JS; Xiao, L; Yang, C | 1 |
| Duraisingh, MT; Jones, P; Pinder, M; Sambou, I; von Seidlein, L; Warhurst, DC | 1 |
| Green, ST; Jones, DA; Leach, MJ; Mainwaring, CJ; Nayak, N; Winfield, DA | 1 |
| Collins, WE; Fryauff, DJ; Galland, GG; Jennings, V; Kendall, J; Morris, CL; Sullivan, JS | 1 |
| Brasseur, P; Cuzin-Ouattara, N; Druilhe, P; Moreno, A; Nebie, I; Sanon, S | 1 |
| Ginsburg, HD; Hoshen, MB; Stein, WD | 1 |
| Anh, CV; Davis, TM; Giang, LT; Hang, NT; Hewitt, S; Quang, HH; Thoa, NT; Thuan, LK; Thuy, PT; Trung, TN; Tuan, NT | 1 |
| Ginsburg, H; Hoshen, MB; Stein, WD | 1 |
6 review(s) available for mefloquine and Parasitemia
| Article | Year |
|---|---|
Mefloquine for preventing malaria in pregnant women.
Topics: Abortion, Spontaneous; Africa South of the Sahara; Antimalarials; Dizziness; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Low Birth Weight; Insecticide-Treated Bednets; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Thailand; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Malaria; Mefloquine; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Stillbirth; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Rural Health; Sesquiterpenes; Suppositories | 1997 |
28 trial(s) available for mefloquine and Parasitemia
| Article | Year |
|---|---|
Comparative study of mefloquine and sulphadoxine-pyrimethamine for malaria prevention among pregnant women with HIV in southwest Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine | 2018 |
Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
Topics: Adult; Antimalarials; Benin; Chemoprevention; Dizziness; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2014 |
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Demography; Drug Therapy, Combination; Endemic Diseases; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Azithromycin; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome; Uganda; Young Adult; Zambia | 2014 |
Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.
Topics: Adolescent; Adult; Algorithms; Antimalarials; Area Under Curve; Drug Combinations; Female; Half-Life; Humans; Malaria; Male; Mefloquine; Models, Statistical; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Young Adult | 2015 |
No Clinical or Molecular Evidence of Plasmodium falciparum Resistance to Artesunate-Mefloquine in Northwestern Brazil.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Combinations; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2016 |
Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Rural Population; Time Factors | 2008 |
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Plasmodium falciparum; Time Factors; Treatment Outcome; Young Adult | 2009 |
[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Female; Fever; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Pilot Projects; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2009 |
Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Therapy, Combination; Fever; Humans; Ibuprofen; Injections, Intravenous; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2010 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Recurrence; Sesquiterpenes; Treatment Outcome; Vomiting | 2003 |
The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Primaquine; Secondary Prevention; Sesquiterpenes | 2003 |
Malaria in a cohort of Javanese migrants to Indonesian Papua.
Topics: Adolescent; Adult; Antimalarials; Child; Chloroquine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Incidence; Indonesia; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Papua New Guinea; Parasitemia; Prevalence; Transients and Migrants | 2003 |
Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Bolivia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Sudan; Treatment Outcome | 2005 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
Mefloquine treatment for uncomplicated falciparum malaria in young children 6-24 months of age in northern Ghana.
Topics: Animals; Antimalarials; Child, Preschool; Cohort Studies; Diarrhea; Female; Ghana; Humans; Infant; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Prospective Studies; Vomiting | 2007 |
Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinine; Sesquiterpenes; Time Factors; Treatment Outcome | 1995 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Humans; Malaria, Falciparum; Malawi; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Prospective Studies; Risk Factors; Rural Population; Seasons | 1996 |
Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Blood; Humans; Malaria, Falciparum; Malawi; Mefloquine; Obstetric Labor Complications; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Rural Population; Treatment Outcome | 1996 |
Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Erythrocytes; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Retrospective Studies; Sesquiterpenes | 1996 |
Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Antimalarials; Biopterins; Drug Therapy, Combination; Female; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Neopterin; Parasitemia; Pentoxifylline; Phenanthrenes; Phosphodiesterase Inhibitors; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tumor Necrosis Factor-alpha | 1997 |
Responses of multidrug-resistant Plasmodium falciparum parasites to mefloquine in Nigerian children.
Topics: Animals; Anti-Infective Agents; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Microbial Sensitivity Tests; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 1997 |
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Pilot Projects; Recurrence; Sesquiterpenes; Suppositories; Thailand | 1998 |
Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Recurrence; Regression Analysis; Sesquiterpenes; Statistics, Nonparametric; Vietnam | 2001 |
55 other study(ies) available for mefloquine and Parasitemia
| Article | Year |
|---|---|
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine.
Topics: Administration, Oral; Anilides; Animals; Antimalarials; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Stereoisomerism; Structure-Activity Relationship; Sulfides; Sulfones; Sulfoxides | 2012 |
Blood schizontocidal and gametocytocidal activity of 3-hydroxy-N'-arylidenepropanehydrazonamides: a new class of antiplasmodial compounds.
Topics: Animals; Antimalarials; Chloroquine; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship | 2014 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Topics: Adoptive Transfer; Animals; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Erythrocytes; Female; Flow Cytometry; Malaria; Mefloquine; Mice; Mice, Inbred C57BL; Parasitemia; Phagocytes; Plasmodium berghei; Plasmodium yoelii | 2017 |
Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice.
Topics: Animals; Antimalarials; Artesunate; Blood; Disease Models, Animal; Fluorescence; Malaria; Mefloquine; Mice; Models, Theoretical; Organisms, Genetically Modified; Parasite Load; Parasitemia; Plasmodium berghei; Staining and Labeling | 2018 |
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Brazil; Chloroquine; Comorbidity; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Parasitemia; Primaquine; Recurrence; Retrospective Studies; Tertiary Care Centers; Thrombocytopenia; Travel; Young Adult | 2014 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
[Cerebral malaria in a pregnant woman].
Topics: Anemia, Hemolytic, Autoimmune; Antimalarials; Brain Infarction; Cesarean Section; Chorioamnionitis; Consciousness Disorders; Doxycycline; Drug Therapy, Combination; Emergencies; Female; Humans; Infant, Newborn; Malaria, Cerebral; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Puerperal Disorders; Radiography; Young Adult | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Patient Compliance; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2010 |
Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Clinical Protocols; Colombia; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Plasmodium falciparum; Primaquine; Treatment Outcome | 2010 |
Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi.
Topics: Animals; Erythrocytes; Female; Malaria; Malaria Vaccines; Mefloquine; Mice; Mice, Inbred CBA; Parasitemia; Plasmodium chabaudi; Species Specificity; Sporozoites; Vaccination | 2011 |
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain; Leukocytes; Malaria, Cerebral; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Quinine | 2011 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sex Factors; Thailand; Time Factors; Treatment Outcome; Young Adult | 2011 |
Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
Topics: Administration, Oral; Animals; Antimalarials; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Dosage Calculations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Malaria; Male; Mefloquine; Mice; Parasitemia; Plasmodium yoelii; Rodent Diseases; Survival Rate; Thailand | 2011 |
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred C57BL; Microscopy; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Quinolines; Secondary Prevention; Survival Rate | 2012 |
Efficacy of mefloquine treatment and genetic profiles in uncomplicated Plasmodium falciparum malaria in southern Lao PDR.
Topics: Antimalarials; Child; Child, Preschool; Female; Genotype; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic | 2011 |
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Retrospective Studies; Thailand; Time Factors; Treatment Outcome; Young Adult | 2012 |
In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Madagascar; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Triazines | 2002 |
Prophylaxis failure due to probable mefloquine resistant P falciparum from Tanzania.
Topics: Adult; Animals; Antimalarials; Drug Resistance; Female; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Tanzania; Travel | 2003 |
Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso.
Topics: Adolescent; Adult; Animals; Antimalarials; Burkina Faso; Chemoprevention; Chloroquine; Cross-Sectional Studies; Culicidae; Disease Vectors; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Insecticides; Malaria, Falciparum; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome | 2003 |
[Malaria--case report].
Topics: Adult; Anti-Infective Agents; Antidiarrheals; Antimalarials; Chloroquine; Ciprofloxacin; Diarrhea; Emergencies; Fluid Therapy; Glasgow Coma Scale; Humans; Loperamide; Malaria, Cerebral; Malaria, Falciparum; Male; Mefloquine; Nigeria; Parasitemia; Positive-Pressure Respiration; Proguanil; Quinine; Respiratory Distress Syndrome; Travel | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Design, synthesis and antimalarial activity of trifluoromethylartemisinin-mefloquine dual molecules.
Topics: Animals; Antimalarials; Artemisinins; Drug Design; Hydrocarbons, Halogenated; Malaria; Mefloquine; Mice; Molecular Structure; Parasitemia; Plasmodium berghei; Plasmodium falciparum | 2005 |
Malaria in an eastern screech owl (Otus asio).
Topics: Animals; Antimalarials; Bird Diseases; Malaria; Mefloquine; Parasitemia; Plasmodium; Strigiformes | 2005 |
Utility of alkylaminoquinolinyl methanols as new antimalarial drugs.
Topics: 3T3 Cells; Animals; Antimalarials; Aotidae; Computer Simulation; Drug Evaluation, Preclinical; Erythrocytes; Female; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Male; Mefloquine; Mice; Microscopy, Confocal; Molecular Structure; Neurons; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Solubility; Structure-Activity Relationship | 2006 |
[A plasmodium alciparum malaria case originated from Mozambique: clues for the diagnosis and therapy].
Topics: Animals; Antimalarials; Canada; Chloroquine; Doxycycline; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Mozambique; Parasitemia; Plasmodium falciparum; Quinine; Secondary Prevention; Travel; Turkey | 2006 |
Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
Topics: Animals; Antimalarials; Artemisinins; Ciprofloxacin; Drug Synergism; Malaria; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Succinates | 2007 |
Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy.
Topics: Animals; Antifibrinolytic Agents; Antimalarials; Glutathione Transferase; Injections, Intraperitoneal; Liver; Malaria; Mefloquine; Mice; Microsomes; Parasitemia; Plasmodium yoelii; Proteins; Spleen; Time Factors; Vitamin K 3 | 2007 |
Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees.
Topics: Adolescent; Ambulatory Care; Antimalarials; Atovaquone; Australia; Child; Child, Preschool; Female; Follow-Up Studies; Hospitalization; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Proguanil; Quinine; Refugees | 2007 |
Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.
Topics: Animals; Antimalarials; Aotidae; Chloroquine; Cytochromes b; Dihydropteroate Synthase; Disease Models, Animal; DNA, Protozoan; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Monkey Diseases; Parasitemia; Peru; Plasmodium falciparum; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase | 2007 |
Anemia and antibodies to the 19-kDa fragment of MSP1 during Plasmodium falciparum infection in Aotus monkeys.
Topics: Anemia; Animals; Antibodies, Protozoan; Antimalarials; Aotidae; Disease Models, Animal; Erythrocytes; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Monkey Diseases; Parasitemia; Plasmodium falciparum | 2007 |
Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
Topics: Adult; Animals; Artemisinins; Artesunate; Blood; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Schizonts; Sesquiterpenes; Thailand; Trophozoites | 2008 |
Plasmodium berghei: selection of mefloquine-resistant parasites through drug pressure in mosquitoes.
Topics: Animals; Anopheles; Dose-Response Relationship, Drug; Drug Resistance; Erythrocytes; Malaria; Mefloquine; Mice; Parasitemia; Plasmodium berghei; Salivary Glands | 1995 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; National Health Programs; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1994 |
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
Topics: Animals; Antimalarials; Chloroquine; Colorimetry; Erythrocytes; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Plasmodium vivax; Quinine | 1995 |
Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Female; Fetal Death; Fever; Humans; Malaria, Falciparum; Malawi; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Rural Population | 1996 |
Malaria in pregnancy: efficacy of a low dose of mefloquine in an area holoendemic for multi-drug resistant Plasmodium falciparum.
Topics: Adult; Antimalarials; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Mefloquine; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome | 1996 |
In vitro drug sensitivity and clinical aspects of Plasmodium falciparum malaria in African children.
Topics: Animals; Child; Child, Preschool; Chloroquine; Congo; Humans; Infant; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Quinine | 1995 |
The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Drug Antagonism; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Naphthyridines; Parasitemia; Phenanthrenes; Phenylpropionates; Plasmodium berghei; Plasmodium yoelii | 1997 |
In vitro blood schizonticidal activity of sera containing mefloquine-quinine against Plasmodium falciparum.
Topics: Animals; Antimalarials; Drug Therapy, Combination; Erythrocytes; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Quinine | 1997 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Carrier State; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Parasitemia; Phenanthrenes; Plasmodium falciparum; Prospective Studies; Quinine; Regression Analysis; Risk Factors; Seroepidemiologic Studies; Sesquiterpenes; Thailand | 1999 |
Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Humans; Immunoassay; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Kinetics; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Pilot Projects; Plasmodium falciparum; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1999 |
Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys.
Topics: Adjuvants, Immunologic; Animals; Antimalarials; Disease Models, Animal; Female; Immunization; Malaria Vaccines; Malaria, Vivax; Male; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy; Vaccines, Synthetic | 1999 |
Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Drug Resistance; Gambia; Hematocrit; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Phenanthrenes; Plasmodium falciparum; Quinine; Scintillation Counting; Sensitivity and Specificity; Sesquiterpenes | 1999 |
Automated exchange transfusion for life-threatening plasmodium falciparum malaria--lessons relating to prophylaxis and treatment.
Topics: Adult; Exchange Transfusion, Whole Blood; Female; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Travel | 1999 |
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
Topics: Adaptation, Physiological; Adult; Amodiaquine; Animals; Antimalarials; Aotidae; Child; Chloroquine; Disease Models, Animal; Drug Resistance; Female; Humans; Indonesia; Malaria, Vivax; Male; Mefloquine; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy | 2000 |
Use of the DELI-microtest to determine the drug sensitivity of Plasmodium falciparum in Burkina Faso.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Malaria, Falciparum; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Reagent Kits, Diagnostic; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
Topics: Animals; Antimalarials; Dose-Response Relationship, Drug; Drug Resistance; Humans; Malaria; Mathematics; Mefloquine; Models, Biological; Models, Chemical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum | 2001 |
Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Models, Biological; Parasitemia; Plasmodium; Sesquiterpenes | 2002 |